the aid library

LIST OPTIONS

Filter

8336

Caring for those who care. Guide for the development and implementation of occupational health and safety programmes for health workers

World Health Organization WHO; ILO (2022) C_WHO

Occupational health and safety programmes aim to prevent diseases and injuries arising out of, linked with or occurring in the course of work, while improving the quality and safety of care, safeguarding the health workforce and promoting environmental sustainability in the health sector. This gu... more

Download (277)

View PDF (299)

National Action Plan of the Islamic Republic of Iran for combating antimicrobial resistance

Ministry of Health and Medical Education Iran (2016) C_WHO

Antimicrobial resistance is one of the most important threats to the health worldwide. Antimicrobial resistance or drug resistance is the reduction of the pharmaceutical effects of a drug against a disease or reduction of its effectiveness in improving the clinical signs of a disease. Antimicrobial ... more

External Link

I-Kit for Ebola Preparedness

Health Communication Capacity Collaborative (HC3); USAID (2015)

This Ebola Communication Preparedness Implementation Kit (I-Kit) provides national and local stakeholders, as well as program managers, with key considerations and a roadmap for instituting and implementing critical, relevant, practical and timely communication for responding to the threat of an Ebo... more

Download (147)

View PDF (166)

Epidemiology and Challenges of Managing COPD in sub-Saharan Africa

Magitta, N.F.; Sciences, A. Acta Scientific Medical Sciences (2018) CC2

There is paucity of data on the burden and specific drivers operative in the pathogenesis of chronic obstructive pulmonary disease (COPD) in the African setting and populations. Lack of awareness and inadequate knowledge on the aetio-pathogenesis of the disease together with inadequate capacity for ... more

Download (433)

View PDF (659)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Download (714)

View PDF (880)

Communicable disease threats report, 11 November 2017

European Centre for Disease Prevention and Control (2017) C1

The ECDC Communicable Disease Threats Report (CDTR) is a weekly bulletin for epidemiologists and health professionals on active public health threats. This issue covers the period 5-11 November 2017 and includes updates on measles, rubella, chikungunya, West Nile virus, Plague, monkeypox, legionnair... more

Download (223)

View PDF (405)

Monkeypox: Current status in West and Central Africa

World Health Organization (WHO) (2018) C_WHO

Monkeypox is an emerging viral zoonosis with symptoms similar to those observed in smallpox patients, although less severe. Since the global eradication of smallpox in 1980, monkeypox has emerged as the most important orthopoxvirus in humans. The Advisory Committee on Variola Virus Research (ACVVR) ... more

Download (324)

View PDF (424)

The impact of Covid-19 on HIV, TB and Malaria Services and Systems for Health: a Snapshot from 502 health facilities across Africa and Asia

The Global Fund (2021) CC

In 2020, the COVID-19 pandemic impacted the world beyond imagination. To date, it has infected more than 135 million people, killed over 2.9 million people, and is projected to plunge up to 115 million people into extreme poverty.1 As countries have gone into lockdown, gender-based violence has incr... more

Manual de Vigilância do Óbito no Contexto da Síndrome Inflamatória Multissistêmica Pediátrica Associada à Covid-19

Ministério da Saúde, Brasil (2021) C2

O Ministério da Saúde (MS), por meio da Coordenação-Geral do Programa Nacional de Imunizações (CGPNI) e da Coordenação-Geral de Informações e Análises Epidemiológicas (CGIAE) da Secretaria de Vigilância em Saúde (SVS) publica o Protocolo de Vigilância do Óbito no Contexto da síndrom... more

Download (206)

View PDF (326)

Recomendaciones psicológicas para explicar a la infancia el brote de Coronavirus-COVID19

Colegio Oficial de Psicología de Madrid (2020) C1

RECOMENDACIONES PSICOLÓGICAS PARA EXPLICAR A NIÑOS Y NIÑAS EL BROTE DE CORONAVIRUS-COVID 19 El Colegio Oficial de la Psicología de Madrid, a través de la Sección de Psicología Clínica, de la Salud y Psicoterapia, quiere transmitir una serie de pautas dirigidas a padres, profesionales y fami... more

External Link

Apercu des Besoins humanitaires 2016

l’Equipe Humanitaire Pays (2015) C2

le Sénégal continue d’être confronté à une crise alimentaire et nutritionnelle qui touche particulièrement le nord et l’est du pays. Selon les estimations faites en novembre 20151, plus de 2,4 millions de personnes sont en insécurité alimentaire (soit 17% de la population), dont 220 461 ... more

External Link

Disability considerations for COVID-19 vaccination

World Health Organization WHO; UNICEF (2021) C_WHO

Available in Chinese, English, French, Russian and Spanish; WHO and UNICEF policy brief, 19 April 2021 Persons with disabilities are disproportionately impacted by COVID-19, both directly because of infection, and indirectly because of restrictions to reduce the spread of the virus. Persons with di... more

Download (223)

View PDF (406)

Guidelines for the use of non-pharmaceutical measures to delay and mitigate the impact of 2019-nCoV

European Centre for Disease Prevention and Control ECDC (2020) C1

This document provides guidance on the application of non-pharmaceutical countermeasures to minimise the spread of the 2019 novel coronavirus (2019-nCoV) in the population. Some of the measures proposed refer specifically to certain phases of the epidemic (containment or mitigation phases), and can ... more

Download (375)

View PDF (470)

Scoping review of interventions to maintain essential services for maternal, newborn, child and adolescent health and older people during disruptive events

World Health Organization WHO (2021) C_WHO

To support countries in adapting their response to different COVID-19 scenarios, the World Health Organization (WHO) Department of Maternal, Newborn, Child and Adolescent Health and Ageing commissioned this scoping review of published and grey literature. The objective was to identify interventions... more

External Link

Formation de l'OMS sur la prise en charge clinique des infections Respiratoires Aiguës Sévères (SARI)
recommended

Organisation Mondiale de la Santé OMS (2020) C1

Ce cours est à destination des cliniciens qui travaillent dans des unités de soins intensifs (ICU) dans les pays à faible et moyen revenu et la prise en charge des patients adultes et pédiatriques atteints de formes d'infection respiratoire aiguë sévère (SARI), notamment la pneumonie sévère... more

Download (202)

View PDF (360)

Directrices provisionales de bioseguridad de laboratorio para el manejo y transporte de muestras asociadas al nuevo coronavirus 2019 (2019-nCoV)

OPS OPS (2020) C_WHO

En enero de 2020, el agente etiológico responsable de un grupo de casos de neumonía grave en Wuhan, China, fue identificado como un nuevo betacoronavirus (2019-nCoV), distinto del SARS-CoV y MERS-CoV (1) (2) (3). La secuencia genómica completa de este nuevo agente está disponible y se han desarr... more

Download (1326)

View PDF (2876)

Manual for the care and management of patients in Ebola Care Units/ Community Care Centres - Interim emergency guidance, January 2015
recommended

World Health Organization (2015)

This manual provides guidance on best practices to be followed in Ebola Care Units (ECUs)/Community Care Centres (CCCs). It is intended for health aid workers (including junior nurses and community health-care workers) and others providing care for patients in ECUs/CCCs. While the focus is on the ca... more

Download (263)

View PDF (446)

Information note on HIV and COVID-19

World Health Organization WHO (2020) C_WHO

People living with HIV depend on life-saving antiretroviral therapy (ART) and access to ART must be maintained during periods of travel restrictions and lockdowns resulting from the COVID-19 pandemic. The Information note on HIV and COVID-19 addresses common concerns people living with HIV have rega... more

Download (247)

View PDF (252)

Clinical management of COVID-19: living guideline, 13 January 2023

World Health Organisation (WHO) (2023) C_WHO

As of 12 December 2022, over 645 million people worldwide have been diagnosed with COVID-19, with over 6.6 million deaths (4). The Omicron variant, which emerged in late November 2021, and its subvariants, are now the dominant circulating viruses, contributing to the ongoing surge in several countr... more

Download (290)

View PDF (534)

Sick Development

Anna Marriott Oxfam International (2023) CC

Development finance institutions owned by European governments and the World Bank Group are spending hundreds of millions of dollars on expensive for-profit hospitals in the Global South that block patients from getting care, or bankrupt them, with some even imprisoning patients who cannot afford th... more

Formation de l'OMS sur la prise en charge clinique des infections Respiratoires Aiguës Sévères (SARI) recommended

Manual for the care and management of patients in Ebola Care Units/ Community Care Centres - Interim emergency guidance, January 2015 recommended

Formation de l'OMS sur la prise en charge clinique des infections Respiratoires Aiguës Sévères (SARI)
recommended

Manual for the care and management of patients in Ebola Care Units/ Community Care Centres - Interim emergency guidance, January 2015
recommended